Telomerase Reverse Transcriptase Gene Promoter Mutations Help Discern the Origin of Urogenital Tumors: A Genomic and Molecular Study-Reference-Cited by-同舟云学术

Telomerase Reverse Transcriptase Gene Promoter Mutations Help Discern the Origin of Urogenital Tumors: A Genomic and Molecular Study

Published:2014-02 Issue:2 Volume:65 Page:274-277
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Wu Song,Huang Peide,Li Chong,Huang Yi,Li Xianxin,Wang Yongqiang,Chen Chao,Lv Zhaojie,Tang Aifa,Sun Xiaojuan,Lu Jingxiao,Li Weiping,Zhou Jie,Gui Yaoting,Zhou Fangjian,Wang Daping,Cai Zhiming

Publisher

Elsevier BV

Subject

Urology

Reference7 articles.

1. Relevance of urine telomerase in the diagnosis of bladder cancer;Sanchini;JAMA,2005

2. Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining;Meeker;Am J Pathol,2002

3. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder;Gui;Nat Genet,2011

4. Multiple tumor suppressor pathways negatively regulate telomerase;Lin;Cell,2003

5. Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines;Stampfer;Oncogene,2003

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial Carcinoma;International Journal of Molecular Sciences;2024-03-26

2. Telomerase Reverse Transcriptase-Promoter Mutation in Young Patients with Bladder Tumors;Current Issues in Molecular Biology;2024-03-23

3. TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.;Pathology - Research and Practice;2024-01

4. Uromonitor®: Clinical Validation and Performance Assessment of a Urinary Biomarker for Recurrence Surveillance in Non-Muscle Invasive Bladder Cancer Patients;2023-11-03

5. Effect of the TERT mutation on the prognosis of patients with urothelial carcinoma: a systematic review and meta-analysis;BMC Urology;2023-11-02